Masimo Corp

MASI

Equity

ISIN US5747951003 / Valor 493578

NASDAQ (2025-04-03)

USD 152.37-11.1%

Masimo Corp
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Masimo Corp is a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies, including pulse oximetry, blood constituent monitoring, and brain function monitoring products.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

In the third quarter of 2024, Masimo Corp reported consolidated revenue of $504.6 million. This figure includes healthcare revenue of $343.3 million, which saw an increase of 11.5% on a reported basis and 11.7% on a constant currency basis, and non-healthcare revenue of $161.3 million.

Net Income

Masimo Corp's GAAP net income for the third quarter of 2024 was $9.8 million, translating to $0.18 per diluted share. On a non-GAAP basis, the net income was significantly higher at $52.9 million, or $0.98 per diluted share.

Operating Income

The company's GAAP operating income for the third quarter of 2024 was reported at $30.1 million. In contrast, the non-GAAP operating income was $80.8 million, indicating adjustments for certain expenses and income items.

Financial Guidance

For the fourth quarter of 2024, Masimo Corp provided guidance with consolidated revenue expected to range between $581 million and $611 million. The full-year 2024 guidance was updated to a range of $2,075 million to $2,105 million, reflecting adjustments from prior estimates.

Strategic Focus

Masimo Corp's interim CEO, Michelle Brennan, emphasized the company's strategic focus on long-term growth potential. This includes a review of the product portfolio and R&D projects, with resources being allocated to fewer projects that address clear unmet needs, while reducing spending in non-contributory areas.

Summarized from source with an LLMView Source

Key figures

8.34%1Y

0.44%3Y

-16.3%5Y

Performance

37.8%1Y

49.9%3Y

43.8%5Y

Volatility